653 related articles for article (PubMed ID: 18664948)
1. Free care at the point of service delivery: a key component for reaching universal access to HIV/AIDS treatment in developing countries.
Souteyrand YP; Collard V; Moatti JP; Grubb I; Guerma T
AIDS; 2008 Jul; 22 Suppl 1():S161-8. PubMed ID: 18664948
[TBL] [Abstract][Full Text] [Related]
2. Access to antiretroviral treatment in developing countries: Which financing strategies are possible?
Beaulière A; Le Maux A; Trehin C; Perez F
Rev Epidemiol Sante Publique; 2010 Jun; 58(3):171-9. PubMed ID: 20430553
[TBL] [Abstract][Full Text] [Related]
3. User fees and access to ARV treatment for persons living with HIV/AIDS: implementation and challenges in Burkina Faso, a limited-resource country.
Kouanda S; Bocoum FY; Doulougou B; Bila B; Yameogo M; Sanou MJ; Sawadogo M; Sondo B; Msellati P; Desclaux A
AIDS Care; 2010 Sep; 22(9):1146-52. PubMed ID: 20824567
[TBL] [Abstract][Full Text] [Related]
4. Recurrent costs of HIV/AIDS-related health services in Rwanda: implications for financing.
Quentin W; König HH; Schmidt JO; Kalk A
Trop Med Int Health; 2008 Oct; 13(10):1245-56. PubMed ID: 18721185
[TBL] [Abstract][Full Text] [Related]
5. The Brazilian experiment: HIV drugs for all.
Flaer PJ; Younis MZ
J Health Care Finance; 2009; 36(2):90-6. PubMed ID: 20499725
[TBL] [Abstract][Full Text] [Related]
6. The obligation to provide antiretroviral treatment in HIV prevention trials.
Lo B; Padian N; Barnes M
AIDS; 2007 Jun; 21(10):1229-31. PubMed ID: 17545698
[TBL] [Abstract][Full Text] [Related]
7. Introduction: the realities of antiretroviral therapy rollout: overcoming challenges to successful programmatic implementation.
Ojikutu B
J Infect Dis; 2007 Dec; 196 Suppl 3():S445-8. PubMed ID: 18181692
[TBL] [Abstract][Full Text] [Related]
8. Obstacles and proposed solutions to effective antiretroviral therapy in resource-limited settings.
Bartlett JA; Hornberger J; Shewade A; Bhor M; Rajagopalan R
J Int Assoc Physicians AIDS Care (Chic); 2009; 8(4):253-68. PubMed ID: 19721103
[TBL] [Abstract][Full Text] [Related]
9. Making choices between prepayment and user charges in Zambia. What are the results for equity?
Kondo M; McPake B
Health Econ; 2007 Dec; 16(12):1371-87. PubMed ID: 17330922
[TBL] [Abstract][Full Text] [Related]
10. Barriers to access to antiretroviral treatment in developing countries: a review.
Posse M; Meheus F; van Asten H; van der Ven A; Baltussen R
Trop Med Int Health; 2008 Jul; 13(7):904-13. PubMed ID: 18466183
[TBL] [Abstract][Full Text] [Related]
11. The impact of Global Health Initiatives at national and sub-national level - a policy analysis of their role in implementation processes of antiretroviral treatment (ART) roll-out in Zambia and South Africa.
Hanefeld J
AIDS Care; 2010; 22 Suppl 1():93-102. PubMed ID: 20680864
[TBL] [Abstract][Full Text] [Related]
12. Poverty and access to health care in developing countries.
Peters DH; Garg A; Bloom G; Walker DG; Brieger WR; Rahman MH
Ann N Y Acad Sci; 2008; 1136():161-71. PubMed ID: 17954679
[TBL] [Abstract][Full Text] [Related]
13. To retain or remove user fees?: reflections on the current debate in low- and middle-income countries.
James CD; Hanson K; McPake B; Balabanova D; Gwatkin D; Hopwood I; Kirunga C; Knippenberg R; Meessen B; Morris SS; Preker A; Souteyrand Y; Tibouti A; Villeneuve P; Xu K
Appl Health Econ Health Policy; 2006; 5(3):137-53. PubMed ID: 17132029
[TBL] [Abstract][Full Text] [Related]
14. Perspectives on the pediatric HIV/AIDS pandemic: catalyzing access of children to care and treatment.
Kline MW
Pediatrics; 2006 Apr; 117(4):1388-93. PubMed ID: 16585337
[TBL] [Abstract][Full Text] [Related]
15. [Financing healthcare in low-income countries: recurring questions, new challenges].
Audibert M; Mathonnat J; de Roodenbeke E
Med Trop (Mars); 2004; 64(6):552-60. PubMed ID: 15816130
[TBL] [Abstract][Full Text] [Related]
16. Health systems and access to antiretroviral drugs for HIV in Southern Africa: service delivery and human resources challenges.
Schneider H; Blaauw D; Gilson L; Chabikuli N; Goudge J
Reprod Health Matters; 2006 May; 14(27):12-23. PubMed ID: 16713875
[TBL] [Abstract][Full Text] [Related]
17. The public health approach to antiretroviral treatment (ART) service scale-up in Ethiopia: the first two years of free ART, 2005-2007.
Assefa Y; Kloos H
Ethiop Med J; 2008 Oct; 46(4):401-6. PubMed ID: 19271406
[TBL] [Abstract][Full Text] [Related]
18. Abolition of user fees: the Uganda paradox.
Nabyonga Orem J; Mugisha F; Kirunga C; Macq J; Criel B
Health Policy Plan; 2011 Nov; 26 Suppl 2():ii41-51. PubMed ID: 22027918
[TBL] [Abstract][Full Text] [Related]
19. [Antiretroviral treatment for HIV infection. Where we are and where we are going?].
Sierra-Madero JG; Franco-San-Sebastián D
Rev Invest Clin; 2004; 56(2):222-31. PubMed ID: 15377075
[TBL] [Abstract][Full Text] [Related]
20. [Impact of access to antiretroviral therapy in Côte d'Ivoire].
Eholié SP; Tanon KA; Folquet-Amorissani M; Ouattara I; Aba YT; Traoré-Ettiegne V; Kakou AR; Aoussi E; Anglaret X; Bissagnéné E
Med Trop (Mars); 2009 Oct; 69(5):520-4. PubMed ID: 20025190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
